Brown Miller Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-4,951
Closed -$202K 126
2023
Q1
$202K Sell
4,951
-28
-0.6% -$1.21K 0.12% 115
2022
Q4
$255K Buy
4,979
+3
+0.1% +$144 0.16% 110
2022
Q3
$217K Buy
4,976
+2
+0% +$97 0.15% 109
2022
Q2
$260K Sell
4,974
-83
-2% -$4.23K 0.18% 99
2022
Q1
$262K Buy
5,057
+3
+0.1% +$156 0.15% 104
2021
Q4
$298K Buy
5,054
+156
+3% +$7.73K 0.17% 101
2021
Q3
$210K Buy
+4,898
New +$217K 0.13% 116

Other funds holding PFE

Brown Miller Wealth Management's PFE Position: Q2 2023 in Review

Brown Miller Wealth Management sold out of Pfizer (PFE) in Q2 2023, closing a stake of 4,951 shares — an estimated $202K sold.

Brown Miller Wealth Management first reported a position in PFE in Q3 2021 and held it in 7 quarters. The position peaked at $298K in Q4 2021. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

  • Brown Miller Wealth Management reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
  • Brown Miller Wealth Management sold 4,951 Pfizer shares in Q2 2023, an estimated $202K.
  • Brown Miller Wealth Management first reported a position in Pfizer in Q3 2021 and held it in 7 quarters.
  • Brown Miller Wealth Management's Pfizer position peaked at $298K in Q4 2021.
  • 3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on Brown Miller Wealth Management's 13F filing for Q2 2023, filed 18 Jul 2023.